Published in J Pharm Biomed Anal on December 06, 2009
Food-drug interactions. Oman Med J (2011) 1.11
Determination of ciprofloxacin in human plasma using high-performance liquid chromatography coupled with fluorescence detection: application to a population pharmacokinetics study in children with severe malnutrition. J Chromatogr B Analyt Technol Biomed Life Sci (2010) 0.88
The effect of milk components, especially of casein, on the bioavailability of ciprofloxacin tablets cannot be evaluated by dissolution testing. J Pharm Biomed Anal (2010) 0.77
Prevalence of accessory tooth cusps in a contemporary and ancestral Hungarian population. Eur J Orthod (2007) 1.22
Fibrous dysplasia associated with intramuscular myxoma (Mazabraud's syndrome): a long-term follow-up of three cases. J Cancer Res Clin Oncol (1998) 1.15
Comparison of the degenerative changes in weight-bearing joints following cementing or grafting techniques in giant cell tumour patients: medium-term results. Int Orthop (2006) 1.03
[Mills' syndrome: a rare clinical entity]. Rev Neurol (Paris) (2007) 1.03
Schizophrenia: redox regulation and volume neurotransmission. Curr Neuropharmacol (2011) 0.90
Application of sucrose fatty acid esters in transdermal therapeutic systems. Eur J Pharm Biopharm (2006) 0.86
Developing and advancing dry powder inhalation towards enhanced therapeutics. Eur J Pharm Sci (2012) 0.85
Molecular manipulation with the arthritogenic epitopes of the G1 domain of human cartilage proteoglycan aggrecan. Clin Exp Immunol (2005) 0.84
Characterization of liposomal vesicles encapsulating rhodanese for cyanide antagonism. Drug Deliv (2009) 0.84
Mid-foot reconstruction following involvement of five bones by giant cell tumor. Skeletal Radiol (2000) 0.84
Surgical treatment and prognostic factors in giant-cell tumor of bone. Acta Chir Orthop Traumatol Cech (2003) 0.83
Liposomal oxytetracycline and doxycycline: studies on enhancement of encapsulation efficiency. Drug Discov Ther (2009) 0.83
Experimental study on the effects of +Gz. Acceleration under gestational conditions. I. Ultrastructural myocardial lesions. Morphol Embryol (Bucur) (1983) 0.80
Determination of alpha-methyldopa in human plasma by validated high-performance liquid chromatography with fluorescence detection. J Chromatogr A (1996) 0.80
Potential application of Metolose in a thermoresponsive transdermal therapeutic system. Int J Pharm (2007) 0.80
Liquid chromatographic and mass spectrometric analysis of human serum acid alpha-1-glycoprotein. Biomed Chromatogr (2004) 0.80
Development of spherical crystals of acetylsalicylic acid for direct tablet-making. Chem Pharm Bull (Tokyo) (2000) 0.80
The single dose pharmacokinetics and safety of deramciclane in healthy male volunteers. Biopharm Drug Dispos (1999) 0.79
Pharmacokinetics and safety of deramciclane during multiple oral dosing. Int J Clin Pharmacol Ther (1999) 0.79
Calcitonin therapy of aneurysmal bone cysts. J Cancer Res Clin Oncol (1992) 0.78
Mass spectrometric characterization of some human metabolites of flumecinol. Biomed Environ Mass Spectrom (1988) 0.78
Visible light induced ocular delayed bioluminescence as a possible origin of negative afterimage. J Photochem Photobiol B (2011) 0.78
Oral, intraperitoneal and intravenous pharmacokinetics of deramciclane and its N-desmethyl metabolite in the rat. J Pharm Pharmacol (2000) 0.78
Formulation of thermoresponsive and bioadhesive gel for treatment of oesophageal pain and inflammation. Eur J Pharm Biopharm (2008) 0.78
Functional outcome and life quality after endoprosthetic reconstruction following malignant tumours around the knee. Int Orthop (2005) 0.77
Pharmacokinetics of panomifene in healthy volunteers at phase I/a study. Anticancer Drugs (1997) 0.77
New formulation of in situ gelling Metolose-based liquid suppository. Drug Dev Ind Pharm (2010) 0.77
Estimation of the number of biophotons involved in the visual perception of a single-object image: biophoton intensity can be considerably higher inside cells than outside. J Photochem Photobiol B (2010) 0.76
Metabolism of moexipril to moexiprilat: determination of in vitro metabolism using HPLC-ES-MS. Med Chem (2007) 0.76
[Clinical experiences of interval treatment with dermatologic agents containing urea]. Z Hautkr (1990) 0.76
Determination of panomifene in human plasma by high-performance liquid chromatography. J Chromatogr A (1994) 0.75
[Evaluation of substrate-binder interfacial interactions]. Acta Pharm Hung (1998) 0.75
In vitro biopharmaceutical investigation of antacid activity in standard dissolution test apparatus. Acta Pharm Hung (1995) 0.75
Examination and evaluation of surgical margins in bone tumours. Comparative pre- and postoperative CT and MR imaging. Int Orthop (1993) 0.75
[Comparative pharmacokinetics of 800 mg of acyclovir-containing Telviran and Zovirax tablets in healthy volunteers]. Acta Pharm Hung (1999) 0.75
Limb saving surgery in bone tumours: experiences in Hungary. Acta Chir Hung (1994) 0.75
[The straight-wire orthodontic method]. Fogorv Sz (1984) 0.75
Evaluation of different mathematical methods describing drug liberation from new, "soft-patch" type matrix systems. Pharm Dev Technol (1999) 0.75
[Pruritic urticarial papules and plaques in pregnancy]. Z Hautkr (1990) 0.75
[Comparative human pharmacokinetic studies of 20 mg nifedipine-containing Cordaflex and Adalat film coated retared tablets]. Acta Pharm Hung (1996) 0.75
Comparison of the stability of different tablet formulations containing folic acid, vitamin B6 and B12. Pharmazie (2001) 0.75
[Role of food interaction pharmacokinetic studies in drug development. Food interaction studies of theophylline and nifedipine retard and buspirone tablets]. Acta Pharm Hung (1998) 0.75
Whole-body autoradiography and quantitative organ-level distribution study of deramciclane in rats. J Pharm Pharmacol (1999) 0.75
[Results of limb-saving surgery and prognostic factors in patients with osteosarcoma]. Orv Hetil (2000) 0.75
In vitro and in vivo metabolisms of K-48. Anal Bioanal Chem (2007) 0.75
The effect of oil as a dietary component on in vitro dissolution of an acid-labile drug. Pharmazie (2003) 0.75
Capillary electrophoretic separation of clomiphene isomers using various cyclodextrins as additives. J Capillary Electrophor (1997) 0.75
Gas chromatographic method for the determination of flumecinol in biological fluids. J Chromatogr (1980) 0.75
Analysis of pyridinium aldoximes - a chromatographic approach. Curr Med Chem (2008) 0.75
[Association of probably tuberculous uveitis with cataracta punctata cerulaea]. Ann Ocul (Paris) (1972) 0.75
[Dual fluorescence in situ hybridization analysis of synovial sarcoma]. Orv Hetil (1999) 0.75
Simple and rapid determination of clomiphene cis and trans isomers in human plasma by high-performance liquid chromatography using on-line post-column photochemical derivatization and fluorescence detection. J Chromatogr (1993) 0.75
High-performance liquid chromatographic determination of the plasma concentration of K-27, a novel oxime-type cholinesterase reactivator. J Chromatogr A (2006) 0.75
Food interaction study of a new theophylline (Egifilin) 200 and 400 mg retard tablet in healthy volunteers. Int J Clin Pharmacol Ther (1997) 0.75
[Preformulation study of controlled release nitrofurantoin preparations. 2]. Acta Pharm Hung (1990) 0.75
Comparative bioavailability studies on two oral diazepam preparations. Acta Pharm Hung (1978) 0.75
[Occupational morbidity and ophthalmological transition pathology in a ready-made clothes factory]. Rev Chir Oncol Radiol O R L Oftalmol Stomatol Ser Oftalmol (1981) 0.75
Sensitive high-performance liquid chromatographic determination of nifedipine in dog plasma using an automated sample preparation system with laboratory robot. J Chromatogr B Biomed Appl (1996) 0.75
Pharmaceutical application of thermoresponsive materials. J Control Release (2005) 0.75
Metabolite analysis, isolation and purity assessment using various liquid chromatographic techniques combined with radioactivity detection. J Chromatogr Sci (2003) 0.75
Distribution of deramciclane (EGIS-3886) in rat brain regions. Eur J Drug Metab Pharmacokinet (1998) 0.75
[Human pharmacokinetic study of nerisopam and its n-acetyl metabolite]. Acta Pharm Hung (1997) 0.75
Pharmacokinetic and bioequivalence study of two gemfibrozil preparations. Arzneimittelforschung (1997) 0.75
Application of overpressured layer chromatography combined with digital autoradiography and mass spectrometry in the study of deramciclane metabolism. J AOAC Int (1999) 0.75
HPLC analysis of K-48 concentration in plasma. Anal Bioanal Chem (2006) 0.75
Comparative bioavailability of two different rectal preparations of piroxicam in man. Eur J Clin Pharmacol (1992) 0.75
[Open bite and its management]. Fogorv Sz (1991) 0.75
[10,000 case treated with accumulated electroshock combined with relaxant therapy]. Orv Hetil (1967) 0.75
Absorption of the new anxiolytic compound deramciclane in rats, dogs and rabbits. Arzneimittelforschung (1998) 0.75
[Pharmacokinetic study of nerisopam and its n-acetyl metabolite in rats]. Acta Pharm Hung (1997) 0.75
Automated determination of levodopa and carbidopa in plasma by high-performance liquid chromatography-electrochemical detection using an on-line flow injection analysis sample pretreatment unit. J Chromatogr B Biomed Sci Appl (1997) 0.75
[Familial case of Papillon-Lefèvre syndrome]. Fogorv Sz (1996) 0.75
[Modification of drug release with application of pharmaceutical technological methods]. Acta Pharm Hung (1999) 0.75
Determination of deramciclane and N-desmethylderamciclane in human plasma by liquid chromatography-tandem mass spectrometry using off-line robotic sample pretreatment. J Chromatogr A (2000) 0.75
Pharmacokinetics of flumecinol in rats. Acta Pharm Hung (1988) 0.75
Pharmacokinetics of deramciclane in rabbits. Arzneimittelforschung (1998) 0.75
Food interaction pharmacokinetic study of cordaflex 20 mg retard filmtablet in healthy volunteers. Int J Clin Pharmacol Ther (1998) 0.75
Formulation of controlled release drug preparations with antacid effect. Pharmazie (1996) 0.75
Pharmacokinetic studies of flumecinol in man and dog. Eur J Drug Metab Pharmacokinet (1982) 0.75
LDH activity in the pregnant uterus of the rat subjected to hypergravitational conditions (2 g). Physiologie (1982) 0.75
[Preformulation study of a controlled-release nitrofurantoin preparation. I]. Acta Pharm Hung (1987) 0.75
[Bioanalysis of gemfibrozil. Comparative human pharmacokinetics of 300 mg of gemfibrozil-containing Innogem and Lopid capsules]. Acta Pharm Hung (1996) 0.75
[Role of mass transfer processes in drug formulation]. Acta Pharm Hung (1996) 0.75
Study of the bone marrow penetration of radioactivity after oral administration of radiolabelled girisopam (EGIS-5810) in mice. Acta Physiol Hung (1998) 0.75
Comparative bioavailability of alpha-methyldopa normal and film tablet formulations after single oral administration in healthy volunteers. Eur J Drug Metab Pharmacokinet (2001) 0.75
[Treatment of the fracture of the caput and collum of the mandible using the Andresen-Häupl appliance]. Fogorv Sz (1989) 0.75
[Validity of a liquid chromatographic (HPLC) method for the determination of ticlopidine in human plasma]. Acta Pharm Hung (1997) 0.75
[Results of using bone cement and phenol lavage in the surgical management of giant cell bone tumors]. Magy Traumatol Orthop Helyreallito Seb (1992) 0.75
Simultaneous determination of nerisopam, a novel anxiolytic agent showing polymorphic metabolism, and its N-acetyl metabolite from human plasma by a validated high performance liquid chromatographic method. J Chromatogr B Biomed Appl (1996) 0.75
Different absorption profiles of deramciclane in man and in dog. J Pharm Pharmacol (1998) 0.75
[Replacement of the atrophied bladder with the sigmoid]. Orv Hetil (1965) 0.75
Quantitative estimation of film forming polymer-plasticizer interactions by the Lorentz-Lorenz Law. Int J Pharm (2006) 0.75
Activity and structural changes in Mg++-dependent and (Na++K+)-activated adenosine triphosphatase prepared from rat brain following detergent treatment. Acta Biochim Biophys Acad Sci Hung (1969) 0.75
Liquid chromatographic method for the determination of ticlopidine in human plasma. J Chromatogr B Biomed Sci Appl (1997) 0.75
Effect of particle size and coating level on the diffuse reflectance of wax matrices. J Pharm Pharmacol (1998) 0.75